News - Generics, Takeda Pharmaceuticals

Filter

Popular Filters

Lundbeck/Takeda's Brintellix has blockbuster potential

02-08-2013

Denmark CNS drug specialist Lundbeck (LUND: CO) and partner Japanese drug major Takeda Pharmaceutical's…

BrintellixedivoxetineEli LillyFetzimaForest LaboratoriesGenericsGlobalLundbeckMarkets & MarketingNeurologicalPharmaceuticalPierre FabreTakeda Pharmaceuticals

Watson gets FDA final approval for generic Actos; negative news on Prochieve appeal

29-10-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) said on Friday that it has launched a generic…

ActosDiabetesGenericsLegalMylan LaboratoriesNorth AmericaProchieveRegulationReproductiveTakeda PharmaceuticalsWatson Pharmaceuticals

Ranbaxy debuts authorized Actos generic in USA, followed by Teva and Mylan

20-08-2012

The US subsidiary of Ranbaxy Laboratories (AB: BO), India's largest drugmaker, has launched authorized…

ActoplusMetActosDiabetesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaRanbaxy LaboratoriesRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Watson sues US FDA regarding generic Actos approval delay

16-08-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) says it has filed suit against the US Food and…

ActosDiabetesGenericsLegalNorth AmericaTakeda PharmaceuticalsWatson Pharmaceuticals

Takeda to acquire Brazil's Multilab for around $249 million

25-05-2012

Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, revealed this morning that it has entered…

GenericsMergers & AcquisitionsMultilabPharmaceuticalSouth AmericaTakeda Pharmaceuticals

Par Pharma acquires Handa's ANDA for generic Dexilant

23-04-2012

USA-based Par Pharmaceutical (NYSE: PRX) has entered into an exclusive acquisition and license agreement…

DexilantGastro-intestinalsGenericsHanda PharmaceuticalsLicensingNorth AmericaPar PharmaceuticalsTakeda Pharmaceuticals

Mylan confirms Actoplus patent challenge

09-01-2012

US generic drugmaker Mylan (Nasdaq: MYL) has confirmed that it has been sued by Takeda Pharmaceutical…

AndrxDiabetesGenericsLegalMylan LaboratoriesNorth AmericaPatentsTakeda PharmaceuticalsWatson Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top